

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | water-soluble vitamin biosynthetic process (GO:0042364) | 6.36432383 |
| 2 | intestinal absorption (GO:0050892) | 6.02389116 |
| 3 | intestinal cholesterol absorption (GO:0030299) | 4.91211092 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.85968563 |
| 5 | endocrine pancreas development (GO:0031018) | 4.58333452 |
| 6 | reverse cholesterol transport (GO:0043691) | 4.50538966 |
| 7 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.45311805 |
| 8 | high-density lipoprotein particle remodeling (GO:0034375) | 4.37040727 |
| 9 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.24851340 |
| 10 | regulation of glucokinase activity (GO:0033131) | 4.07625994 |
| 11 | regulation of hexokinase activity (GO:1903299) | 4.07625994 |
| 12 | purine ribonucleotide transport (GO:0015868) | 4.00541268 |
| 13 | adenine nucleotide transport (GO:0051503) | 3.99056510 |
| 14 | lactate metabolic process (GO:0006089) | 3.97497343 |
| 15 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.85582636 |
| 16 | protein-lipid complex remodeling (GO:0034368) | 3.81447877 |
| 17 | macromolecular complex remodeling (GO:0034367) | 3.81447877 |
| 18 | plasma lipoprotein particle remodeling (GO:0034369) | 3.81447877 |
| 19 | purine nucleotide transport (GO:0015865) | 3.81254898 |
| 20 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80552005 |
| 21 | positive regulation of glycolytic process (GO:0045821) | 3.79626289 |
| 22 | urea metabolic process (GO:0019627) | 3.78750679 |
| 23 | urea cycle (GO:0000050) | 3.78750679 |
| 24 | negative regulation of acute inflammatory response (GO:0002674) | 3.78527474 |
| 25 | lipoprotein metabolic process (GO:0042157) | 3.78267333 |
| 26 | insulin secretion (GO:0030073) | 3.78003034 |
| 27 | negative regulation of protein oligomerization (GO:0032460) | 3.76054441 |
| 28 | regulation of protein glycosylation (GO:0060049) | 3.74451281 |
| 29 | regulation of tight junction assembly (GO:2000810) | 3.72975959 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 3.72592023 |
| 31 | homocysteine metabolic process (GO:0050667) | 3.67676429 |
| 32 | cytochrome complex assembly (GO:0017004) | 3.66111224 |
| 33 | protein-lipid complex assembly (GO:0065005) | 3.65917397 |
| 34 | vitamin biosynthetic process (GO:0009110) | 3.65701160 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.65504472 |
| 36 | drug catabolic process (GO:0042737) | 3.64924486 |
| 37 | regulation of female gonad development (GO:2000194) | 3.60222737 |
| 38 | plasma lipoprotein particle assembly (GO:0034377) | 3.59667330 |
| 39 | cholesterol efflux (GO:0033344) | 3.58174143 |
| 40 | respiratory chain complex IV assembly (GO:0008535) | 3.57528755 |
| 41 | phospholipid efflux (GO:0033700) | 3.52607303 |
| 42 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.50927286 |
| 43 | negative regulation of glycogen metabolic process (GO:0070874) | 3.49542248 |
| 44 | cysteine metabolic process (GO:0006534) | 3.48115647 |
| 45 | inositol phosphate catabolic process (GO:0071545) | 3.45731420 |
| 46 | peptide hormone processing (GO:0016486) | 3.44920826 |
| 47 | signal peptide processing (GO:0006465) | 3.42763435 |
| 48 | positive regulation of protein autophosphorylation (GO:0031954) | 3.41710070 |
| 49 | nitric oxide mediated signal transduction (GO:0007263) | 3.41704794 |
| 50 | flavonoid metabolic process (GO:0009812) | 3.41258033 |
| 51 | sulfur amino acid catabolic process (GO:0000098) | 3.41127789 |
| 52 | negative regulation of hormone metabolic process (GO:0032351) | 3.40659908 |
| 53 | epoxygenase P450 pathway (GO:0019373) | 3.38567359 |
| 54 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.38014277 |
| 55 | ovulation cycle (GO:0042698) | 3.37849538 |
| 56 | alpha-linolenic acid metabolic process (GO:0036109) | 3.35482578 |
| 57 | DNA deamination (GO:0045006) | 3.34976751 |
| 58 | positive regulation of respiratory burst (GO:0060267) | 3.32626773 |
| 59 | hormone catabolic process (GO:0042447) | 3.31727089 |
| 60 | protein-lipid complex subunit organization (GO:0071825) | 3.29064234 |
| 61 | negative regulation of membrane potential (GO:0045837) | 3.28911106 |
| 62 | inositol phosphate dephosphorylation (GO:0046855) | 3.26623781 |
| 63 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.26623781 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 3.26139130 |
| 65 | ketone body metabolic process (GO:1902224) | 3.25554616 |
| 66 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.24887561 |
| 67 | carnitine metabolic process (GO:0009437) | 3.23319914 |
| 68 | plasma lipoprotein particle organization (GO:0071827) | 3.23074324 |
| 69 | nitrogen cycle metabolic process (GO:0071941) | 3.22435557 |
| 70 | magnesium ion transport (GO:0015693) | 3.21952501 |
| 71 | regulation of cholesterol esterification (GO:0010872) | 3.18262376 |
| 72 | negative regulation of fibrinolysis (GO:0051918) | 3.16558796 |
| 73 | glandular epithelial cell differentiation (GO:0002067) | 3.12077404 |
| 74 | response to pheromone (GO:0019236) | 3.12019981 |
| 75 | regulation of triglyceride catabolic process (GO:0010896) | 3.11213021 |
| 76 | L-fucose catabolic process (GO:0042355) | 3.10607214 |
| 77 | fucose catabolic process (GO:0019317) | 3.10607214 |
| 78 | L-fucose metabolic process (GO:0042354) | 3.10607214 |
| 79 | chondrocyte proliferation (GO:0035988) | 3.10124625 |
| 80 | keratinocyte development (GO:0003334) | 3.08256547 |
| 81 | protein complex biogenesis (GO:0070271) | 3.08057392 |
| 82 | angiotensin maturation (GO:0002003) | 3.06802658 |
| 83 | prenylation (GO:0097354) | 3.06162847 |
| 84 | protein prenylation (GO:0018342) | 3.06162847 |
| 85 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.04456045 |
| 86 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.04456045 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 3.02878803 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 3.02834030 |
| 89 | zinc ion homeostasis (GO:0055069) | 3.02370769 |
| 90 | notochord development (GO:0030903) | 2.97935229 |
| 91 | zinc ion transmembrane transport (GO:0071577) | 2.97356973 |
| 92 | phospholipid homeostasis (GO:0055091) | 2.96708801 |
| 93 | positive regulation of peptide hormone secretion (GO:0090277) | 2.89280935 |
| 94 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.88307440 |
| 95 | sterol homeostasis (GO:0055092) | 2.88194843 |
| 96 | negative regulation of protein activation cascade (GO:2000258) | 2.87310694 |
| 97 | cholesterol homeostasis (GO:0042632) | 2.86366528 |
| 98 | urate metabolic process (GO:0046415) | 2.86211129 |
| 99 | cholesterol transport (GO:0030301) | 2.85839203 |
| 100 | sterol transport (GO:0015918) | 2.85839203 |
| 101 | regulation of neurotransmitter uptake (GO:0051580) | 2.85614906 |
| 102 | dentate gyrus development (GO:0021542) | 2.85123889 |
| 103 | gap junction assembly (GO:0016264) | 2.84110711 |
| 104 | retinal metabolic process (GO:0042574) | 2.83331944 |
| 105 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.83024095 |
| 106 | positive regulation of actin filament depolymerization (GO:0030836) | 2.82629113 |
| 107 | positive regulation of insulin secretion (GO:0032024) | 2.80943954 |
| 108 | polyol catabolic process (GO:0046174) | 2.78688210 |
| 109 | alanine transport (GO:0032328) | 2.78049817 |
| 110 | bile acid and bile salt transport (GO:0015721) | 2.77038605 |
| 111 | cellular biogenic amine catabolic process (GO:0042402) | 2.76205676 |
| 112 | amine catabolic process (GO:0009310) | 2.76205676 |
| 113 | positive regulation of peptide secretion (GO:0002793) | 2.75691521 |
| 114 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.74071066 |
| 115 | negative regulation of complement activation (GO:0045916) | 2.72345566 |
| 116 | sulfation (GO:0051923) | 2.72170552 |
| 117 | xenobiotic catabolic process (GO:0042178) | 2.72086898 |
| 118 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.70030338 |
| 119 | prostate gland growth (GO:0060736) | 2.70023178 |
| 120 | heme transport (GO:0015886) | 2.68910085 |
| 121 | cell adhesion mediated by integrin (GO:0033627) | 2.68627096 |
| 122 | glycerophospholipid catabolic process (GO:0046475) | 2.67639023 |
| 123 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.67627730 |
| 124 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.66996362 |
| 125 | regulation of acrosome reaction (GO:0060046) | 2.66818453 |
| 126 | negative regulation of sodium ion transport (GO:0010766) | 2.66204849 |
| 127 | negative regulation of lipid transport (GO:0032369) | 2.63977248 |
| 128 | negative regulation of neurological system process (GO:0031645) | 2.63471931 |
| 129 | digestive system process (GO:0022600) | 2.61171504 |
| 130 | regulation of fibrinolysis (GO:0051917) | 2.60645348 |
| 131 | platelet dense granule organization (GO:0060155) | 2.60327020 |
| 132 | cobalamin metabolic process (GO:0009235) | 2.59947150 |
| 133 | positive regulation of lipid catabolic process (GO:0050996) | 2.59572943 |
| 134 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.59518575 |
| 135 | positive regulation of meiosis (GO:0045836) | 2.58775575 |
| 136 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.58656305 |
| 137 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.57352286 |
| 138 | negative regulation of cholesterol transport (GO:0032375) | 2.56987209 |
| 139 | negative regulation of sterol transport (GO:0032372) | 2.56987209 |
| 140 | parental behavior (GO:0060746) | 2.56688067 |
| 141 | one-carbon metabolic process (GO:0006730) | 2.55996349 |
| 142 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.55991156 |
| 143 | zinc ion transport (GO:0006829) | 2.55845019 |
| 144 | energy homeostasis (GO:0097009) | 2.55784080 |
| 145 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.55110610 |
| 146 | inositol phosphate-mediated signaling (GO:0048016) | 2.53564857 |
| 147 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.53535448 |
| 148 | triglyceride homeostasis (GO:0070328) | 2.52579795 |
| 149 | acylglycerol homeostasis (GO:0055090) | 2.52579795 |
| 150 | regulation of plasminogen activation (GO:0010755) | 2.52366878 |
| 151 | axoneme assembly (GO:0035082) | 2.51775469 |
| 152 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.51676796 |
| 153 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.51676796 |
| 154 | peptide secretion (GO:0002790) | 2.51514412 |
| 155 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.50268482 |
| 156 | female gamete generation (GO:0007292) | 2.49941565 |
| 157 | cellular zinc ion homeostasis (GO:0006882) | 2.49505816 |
| 158 | nucleoside transport (GO:0015858) | 2.49345937 |
| 159 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.49063197 |
| 160 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.48880236 |
| 161 | peptide hormone secretion (GO:0030072) | 2.47368843 |
| 162 | establishment of protein localization to Golgi (GO:0072600) | 2.47359366 |
| 163 | protein targeting to Golgi (GO:0000042) | 2.45948297 |
| 164 | regulation of protein autophosphorylation (GO:0031952) | 2.45731774 |
| 165 | positive regulation of meiotic cell cycle (GO:0051446) | 2.44164710 |
| 166 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.44041259 |
| 167 | negative regulation of protein autophosphorylation (GO:0031953) | 2.43975360 |
| 168 | citrulline biosynthetic process (GO:0019240) | 2.43890769 |
| 169 | transcytosis (GO:0045056) | 2.43453665 |
| 170 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.43360258 |
| 171 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.42921853 |
| 172 | regulation of lipoprotein metabolic process (GO:0050746) | 2.42507629 |
| 173 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.41684462 |
| 174 | regulation of energy homeostasis (GO:2000505) | 2.40791757 |
| 175 | low-density lipoprotein particle remodeling (GO:0034374) | 2.40363170 |
| 176 | cartilage morphogenesis (GO:0060536) | 2.40256715 |
| 177 | negative regulation of fatty acid transport (GO:2000192) | 2.39830124 |
| 178 | piRNA metabolic process (GO:0034587) | 2.39497600 |
| 179 | negative regulation of gluconeogenesis (GO:0045721) | 2.38716460 |
| 180 | negative regulation of circadian rhythm (GO:0042754) | 2.38680647 |
| 181 | negative regulation of steroid metabolic process (GO:0045939) | 2.38147632 |
| 182 | epithelial cell fate commitment (GO:0072148) | 2.38004650 |
| 183 | proline transport (GO:0015824) | 2.37867478 |
| 184 | sulfate transmembrane transport (GO:1902358) | 2.37179143 |
| 185 | regulation of insulin secretion (GO:0050796) | 2.37169558 |
| 186 | peptide transport (GO:0015833) | 2.36869530 |
| 187 | kynurenine metabolic process (GO:0070189) | 2.36279342 |
| 188 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.36221922 |
| 189 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.36221922 |
| 190 | S-adenosylmethionine metabolic process (GO:0046500) | 2.36023957 |
| 191 | regulation of glomerulus development (GO:0090192) | 2.35781185 |
| 192 | positive regulation of macroautophagy (GO:0016239) | 2.35277555 |
| 193 | regulation of mesoderm development (GO:2000380) | 2.35233217 |
| 194 | protein K6-linked ubiquitination (GO:0085020) | 2.35167562 |
| 195 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.35021295 |
| 196 | positive regulation of response to nutrient levels (GO:0032109) | 2.35021295 |
| 197 | cellular glucuronidation (GO:0052695) | 2.34697979 |
| 198 | midgut development (GO:0007494) | 2.34303290 |
| 199 | positive regulation of fatty acid oxidation (GO:0046321) | 2.34255615 |
| 200 | lipid homeostasis (GO:0055088) | 2.33142344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.90759418 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.52990894 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.83441407 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71845395 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.62291552 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.60475050 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59928120 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.50595923 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.13421892 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.08902013 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.99205305 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.97140633 |
| 13 | TP53_16413492_ChIP-PET_HCT116_Human | 1.95742354 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 1.92407234 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.90305521 |
| 16 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.90277036 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.89591681 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.80291115 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.79783287 |
| 20 | EWS_26573619_Chip-Seq_HEK293_Human | 1.76179732 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.74062975 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72117930 |
| 23 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.70758004 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.69204671 |
| 25 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.69179164 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.68408614 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.59813888 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.59807050 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.59629076 |
| 30 | CJUN_26792858_Chip-Seq_BT549_Human | 1.57500366 |
| 31 | RXR_22108803_ChIP-Seq_LS180_Human | 1.57102222 |
| 32 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.54953864 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52218351 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49773690 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49452212 |
| 36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48783642 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47202214 |
| 38 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46444792 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.46219883 |
| 40 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.45051494 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44014835 |
| 42 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.42291990 |
| 43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41976180 |
| 44 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.41853515 |
| 45 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.41624315 |
| 46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.41404982 |
| 47 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.40081757 |
| 48 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.40081757 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.39999076 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38942457 |
| 51 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.38649749 |
| 52 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.38649749 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.38448425 |
| 54 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.38448425 |
| 55 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.37661237 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36942773 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36436119 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36436119 |
| 59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35840144 |
| 60 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.35199848 |
| 61 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35123094 |
| 62 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.34327267 |
| 63 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.33981596 |
| 64 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.32831001 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32830458 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32636545 |
| 67 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32443435 |
| 68 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.31784030 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31696100 |
| 70 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.31650966 |
| 71 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.31628417 |
| 72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.31448063 |
| 73 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.31184678 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31177792 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28848874 |
| 76 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27721724 |
| 77 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.26973992 |
| 78 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.26535710 |
| 79 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.25557926 |
| 80 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25521636 |
| 81 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.25459365 |
| 82 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.25437490 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24440481 |
| 84 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22997046 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.22923812 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22497551 |
| 87 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22199247 |
| 88 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20972528 |
| 89 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.20179070 |
| 90 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.19714830 |
| 91 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.19674934 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.19209086 |
| 93 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.19168604 |
| 94 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19069230 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18615734 |
| 96 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17642692 |
| 97 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17234835 |
| 98 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16180668 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15705784 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15272331 |
| 101 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.14862047 |
| 102 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14346755 |
| 103 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.13913867 |
| 104 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.13823252 |
| 105 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13381547 |
| 106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13238167 |
| 107 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12789704 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12679137 |
| 109 | AR_20517297_ChIP-Seq_VCAP_Human | 1.12518608 |
| 110 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.12138470 |
| 111 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12034104 |
| 112 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11602979 |
| 113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11424218 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11263048 |
| 115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11192359 |
| 116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10309148 |
| 117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10238288 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10166930 |
| 119 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.09887601 |
| 120 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09535984 |
| 121 | NCOR_22424771_ChIP-Seq_293T_Human | 1.09352864 |
| 122 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08978492 |
| 123 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08383112 |
| 124 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08073008 |
| 125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08035471 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.07657443 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07214070 |
| 128 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.05959636 |
| 129 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04605753 |
| 130 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03112038 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02034410 |
| 132 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.01461951 |
| 133 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.01100302 |
| 134 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.00884242 |
| 135 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.00632695 |
| 136 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.99727901 |
| 137 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99653229 |
| 138 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.99374250 |
| 139 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99084670 |
| 140 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99078113 |
| 141 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98297996 |
| 142 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98293499 |
| 143 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97809527 |
| 144 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97676181 |
| 145 | AR_19668381_ChIP-Seq_PC3_Human | 0.96189271 |
| 146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95879252 |
| 147 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95471773 |
| 148 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95112821 |
| 149 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93247583 |
| 150 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93059943 |
| 151 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92684669 |
| 152 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91564143 |
| 153 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.90315430 |
| 154 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90267015 |
| 155 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90200678 |
| 156 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89766647 |
| 157 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89698672 |
| 158 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.89410172 |
| 159 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89289178 |
| 160 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88613239 |
| 161 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88594462 |
| 162 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88328396 |
| 163 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86572911 |
| 164 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.86423797 |
| 165 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.86357577 |
| 166 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86187582 |
| 167 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85885116 |
| 168 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85252150 |
| 169 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.84175993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.54162777 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.60925436 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.57929055 |
| 4 | MP0009384_cardiac_valve_regurgitation | 4.42949961 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.99206547 |
| 6 | MP0002163_abnormal_gland_morphology | 3.29540297 |
| 7 | MP0003787_abnormal_imprinting | 3.27716869 |
| 8 | MP0005379_endocrine/exocrine_gland_phen | 3.19410922 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.19352929 |
| 10 | MP0005377_hearing/vestibular/ear_phenot | 3.10247916 |
| 11 | MP0003878_abnormal_ear_physiology | 3.10247916 |
| 12 | MP0003252_abnormal_bile_duct | 3.07228043 |
| 13 | MP0005365_abnormal_bile_salt | 3.03066549 |
| 14 | MP0002254_reproductive_system_inflammat | 2.90026788 |
| 15 | MP0003283_abnormal_digestive_organ | 2.88419114 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.77537812 |
| 17 | MP0003718_maternal_effect | 2.72394609 |
| 18 | MP0005451_abnormal_body_composition | 2.64052079 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.58383235 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36542243 |
| 21 | MP0000566_synostosis | 2.36306082 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 2.35740059 |
| 23 | MP0009840_abnormal_foam_cell | 2.31076085 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.30184662 |
| 25 | MP0009697_abnormal_copulation | 2.29502499 |
| 26 | MP0005670_abnormal_white_adipose | 2.14181675 |
| 27 | MP0002693_abnormal_pancreas_physiology | 2.08665183 |
| 28 | MP0000516_abnormal_urinary_system | 2.00513815 |
| 29 | MP0005367_renal/urinary_system_phenotyp | 2.00513815 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.98580842 |
| 31 | MP0006072_abnormal_retinal_apoptosis | 1.98243305 |
| 32 | MP0003122_maternal_imprinting | 1.95418064 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.92280346 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.90796743 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.87434931 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.82267045 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.80355424 |
| 38 | MP0005395_other_phenotype | 1.73537888 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.71497884 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.70288549 |
| 41 | MP0002102_abnormal_ear_morphology | 1.63763786 |
| 42 | MP0004885_abnormal_endolymph | 1.60573031 |
| 43 | MP0005332_abnormal_amino_acid | 1.56787959 |
| 44 | MP0000462_abnormal_digestive_system | 1.56214390 |
| 45 | MP0005220_abnormal_exocrine_pancreas | 1.54755022 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.54355427 |
| 47 | MP0003279_aneurysm | 1.51233961 |
| 48 | MP0000579_abnormal_nail_morphology | 1.51054363 |
| 49 | MP0004270_analgesia | 1.46061151 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.44495916 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.44230366 |
| 52 | MP0003646_muscle_fatigue | 1.43056939 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.42691656 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.42361112 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.36546028 |
| 56 | MP0004133_heterotaxia | 1.35574006 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.34415174 |
| 58 | MP0003091_abnormal_cell_migration | 1.34052504 |
| 59 | MP0003699_abnormal_female_reproductive | 1.33272986 |
| 60 | MP0003121_genomic_imprinting | 1.31455652 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 1.29335462 |
| 62 | MP0001765_abnormal_ion_homeostasis | 1.29230911 |
| 63 | MP0002089_abnormal_postnatal_growth/wei | 1.28421443 |
| 64 | MP0002160_abnormal_reproductive_system | 1.28420769 |
| 65 | MP0003868_abnormal_feces_composition | 1.28114811 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.27227789 |
| 67 | MP0001299_abnormal_eye_distance/ | 1.24444403 |
| 68 | MP0001756_abnormal_urination | 1.24425814 |
| 69 | MP0005389_reproductive_system_phenotype | 1.23926238 |
| 70 | MP0003123_paternal_imprinting | 1.22993858 |
| 71 | MP0001915_intracranial_hemorrhage | 1.21642465 |
| 72 | MP0005253_abnormal_eye_physiology | 1.21615861 |
| 73 | MP0002938_white_spotting | 1.21199206 |
| 74 | MP0001501_abnormal_sleep_pattern | 1.20931206 |
| 75 | MP0001984_abnormal_olfaction | 1.19786173 |
| 76 | MP0009053_abnormal_anal_canal | 1.19304495 |
| 77 | MP0002638_abnormal_pupillary_reflex | 1.18663681 |
| 78 | MP0008872_abnormal_physiological_respon | 1.18489879 |
| 79 | MP0003950_abnormal_plasma_membrane | 1.14774102 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.14736172 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 1.12577040 |
| 82 | MP0005647_abnormal_sex_gland | 1.11813120 |
| 83 | MP0003195_calcinosis | 1.11306639 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 1.11009317 |
| 85 | MP0001881_abnormal_mammary_gland | 1.09212292 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 1.08485412 |
| 87 | MP0010030_abnormal_orbit_morphology | 1.08068073 |
| 88 | MP0005187_abnormal_penis_morphology | 1.07304577 |
| 89 | MP0005448_abnormal_energy_balance | 1.05576806 |
| 90 | MP0004043_abnormal_pH_regulation | 1.04590799 |
| 91 | MP0001119_abnormal_female_reproductive | 1.02591682 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 1.01915285 |
| 93 | MP0003045_fibrosis | 1.01850465 |
| 94 | MP0003011_delayed_dark_adaptation | 1.01785297 |
| 95 | MP0001986_abnormal_taste_sensitivity | 1.01032918 |
| 96 | MP0000609_abnormal_liver_physiology | 1.00979653 |
| 97 | MP0009745_abnormal_behavioral_response | 1.00233465 |
| 98 | MP0002168_other_aberrant_phenotype | 0.99338343 |
| 99 | MP0002295_abnormal_pulmonary_circulatio | 0.97872286 |
| 100 | MP0000427_abnormal_hair_cycle | 0.97387190 |
| 101 | MP0003937_abnormal_limbs/digits/tail_de | 0.97317143 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.97045737 |
| 103 | MP0001968_abnormal_touch/_nociception | 0.96733633 |
| 104 | MP0009643_abnormal_urine_homeostasis | 0.96316194 |
| 105 | MP0009046_muscle_twitch | 0.96170715 |
| 106 | MP0001485_abnormal_pinna_reflex | 0.95589763 |
| 107 | MP0003119_abnormal_digestive_system | 0.95332605 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.94313430 |
| 109 | MP0005535_abnormal_body_temperature | 0.94157785 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.93634975 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.92446235 |
| 112 | MP0001502_abnormal_circadian_rhythm | 0.92364863 |
| 113 | MP0000647_abnormal_sebaceous_gland | 0.90143898 |
| 114 | MP0005023_abnormal_wound_healing | 0.88764353 |
| 115 | MP0001905_abnormal_dopamine_level | 0.88334259 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.88124696 |
| 117 | MP0006292_abnormal_olfactory_placode | 0.87139814 |
| 118 | MP0003566_abnormal_cell_adhesion | 0.84624253 |
| 119 | MP0000767_abnormal_smooth_muscle | 0.84440146 |
| 120 | MP0001764_abnormal_homeostasis | 0.84140566 |
| 121 | MP0001188_hyperpigmentation | 0.84004107 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.83702218 |
| 123 | MP0005503_abnormal_tendon_morphology | 0.83352662 |
| 124 | MP0000538_abnormal_urinary_bladder | 0.83269482 |
| 125 | * MP0003953_abnormal_hormone_level | 0.81858956 |
| 126 | MP0002272_abnormal_nervous_system | 0.81764369 |
| 127 | MP0001849_ear_inflammation | 0.80572906 |
| 128 | MP0003724_increased_susceptibility_to | 0.80355853 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.78625070 |
| 130 | MP0004272_abnormal_basement_membrane | 0.76407892 |
| 131 | MP0006054_spinal_hemorrhage | 0.76192493 |
| 132 | MP0002090_abnormal_vision | 0.75849254 |
| 133 | MP0010678_abnormal_skin_adnexa | 0.75713701 |
| 134 | MP0000613_abnormal_salivary_gland | 0.75085952 |
| 135 | MP0010368_abnormal_lymphatic_system | 0.74801747 |
| 136 | MP0002896_abnormal_bone_mineralization | 0.74468195 |
| 137 | MP0002734_abnormal_mechanical_nocicepti | 0.74193808 |
| 138 | MP0000627_abnormal_mammary_gland | 0.74068367 |
| 139 | MP0004147_increased_porphyrin_level | 0.73666588 |
| 140 | MP0008004_abnormal_stomach_pH | 0.72199503 |
| 141 | MP0004142_abnormal_muscle_tone | 0.72115068 |
| 142 | MP0002932_abnormal_joint_morphology | 0.71007521 |
| 143 | MP0003755_abnormal_palate_morphology | 0.70501252 |
| 144 | MP0004215_abnormal_myocardial_fiber | 0.70471118 |
| 145 | MP0001919_abnormal_reproductive_system | 0.70071359 |
| 146 | * MP0002557_abnormal_social/conspecific_i | 0.69699452 |
| 147 | MP0003115_abnormal_respiratory_system | 0.69152491 |
| 148 | MP0000428_abnormal_craniofacial_morphol | 0.68926652 |
| 149 | MP0001970_abnormal_pain_threshold | 0.67563866 |
| 150 | MP0001346_abnormal_lacrimal_gland | 0.67459630 |
| 151 | MP0005666_abnormal_adipose_tissue | 0.67425445 |
| 152 | MP0003890_abnormal_embryonic-extraembry | 0.67163622 |
| 153 | MP0002064_seizures | 0.66982059 |
| 154 | MP0001243_abnormal_dermal_layer | 0.64959902 |
| 155 | MP0003183_abnormal_peptide_metabolism | 0.64651950 |
| 156 | MP0000569_abnormal_digit_pigmentation | 0.64208374 |
| 157 | MP0000537_abnormal_urethra_morphology | 0.63925346 |
| 158 | MP0002060_abnormal_skin_morphology | 0.61527894 |
| 159 | MP0002876_abnormal_thyroid_physiology | 0.60297841 |
| 160 | MP0000733_abnormal_muscle_development | 0.59820289 |
| 161 | MP0000163_abnormal_cartilage_morphology | 0.59542219 |
| 162 | MP0000467_abnormal_esophagus_morphology | 0.58797972 |
| 163 | MP0002928_abnormal_bile_duct | 0.57945666 |
| 164 | MP0002115_abnormal_skeleton_extremities | 0.56023443 |
| 165 | MP0003329_amyloid_beta_deposits | 0.55792760 |
| 166 | MP0005595_abnormal_vascular_smooth | 0.55755725 |
| 167 | MP0002249_abnormal_larynx_morphology | 0.55011698 |
| 168 | MP0009250_abnormal_appendicular_skeleto | 0.54838527 |
| 169 | MP0000432_abnormal_head_morphology | 0.54486673 |
| 170 | MP0001177_atelectasis | 0.54002341 |
| 171 | MP0000639_abnormal_adrenal_gland | 0.53862087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia involving bones of the upper limbs (HP:0009823) | 5.16835646 |
| 2 | Aplasia of the phalanges of the hand (HP:0009802) | 5.16835646 |
| 3 | Aplasia involving bones of the extremities (HP:0009825) | 5.16835646 |
| 4 | Hypoglycemic seizures (HP:0002173) | 4.93401913 |
| 5 | Alopecia of scalp (HP:0002293) | 4.77111071 |
| 6 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.44222738 |
| 7 | Hypoglycemic coma (HP:0001325) | 4.35855515 |
| 8 | Ketoacidosis (HP:0001993) | 4.19224627 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.02298897 |
| 10 | Hypothermia (HP:0002045) | 3.89117804 |
| 11 | Abnormality of vitamin B metabolism (HP:0004340) | 3.83888075 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.77904164 |
| 13 | Methylmalonic acidemia (HP:0002912) | 3.71307238 |
| 14 | Follicular hyperkeratosis (HP:0007502) | 3.59718746 |
| 15 | Symptomatic seizures (HP:0011145) | 3.57834865 |
| 16 | Onycholysis (HP:0001806) | 3.42659021 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.39689855 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.34780611 |
| 19 | Neoplasm of the adrenal cortex (HP:0100641) | 3.34080434 |
| 20 | Hypobetalipoproteinemia (HP:0003563) | 3.30006116 |
| 21 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.20808327 |
| 22 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.20808327 |
| 23 | Intrahepatic cholestasis (HP:0001406) | 3.20403679 |
| 24 | Methylmalonic aciduria (HP:0012120) | 3.17779846 |
| 25 | Ketosis (HP:0001946) | 3.17262407 |
| 26 | Hematochezia (HP:0002573) | 3.15745579 |
| 27 | Abnormality of proline metabolism (HP:0010907) | 3.15172298 |
| 28 | Hydroxyprolinuria (HP:0003080) | 3.15172298 |
| 29 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.13110834 |
| 30 | Xanthomatosis (HP:0000991) | 3.11274640 |
| 31 | Thyroiditis (HP:0100646) | 3.06492661 |
| 32 | Protrusio acetabuli (HP:0003179) | 3.06282571 |
| 33 | Abnormality of nail color (HP:0100643) | 3.00424688 |
| 34 | Conjunctival hamartoma (HP:0100780) | 2.98737342 |
| 35 | Large for gestational age (HP:0001520) | 2.87986051 |
| 36 | Abnormal pancreas size (HP:0012094) | 2.86025708 |
| 37 | Abnormality of vitamin metabolism (HP:0100508) | 2.85005043 |
| 38 | Blepharitis (HP:0000498) | 2.84940996 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.83257520 |
| 40 | Acanthocytosis (HP:0001927) | 2.77705209 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.74884097 |
| 42 | Cutaneous melanoma (HP:0012056) | 2.73764475 |
| 43 | Pancreatic fibrosis (HP:0100732) | 2.72775248 |
| 44 | Intestinal atresia (HP:0011100) | 2.71695739 |
| 45 | Pancreatic cysts (HP:0001737) | 2.70513571 |
| 46 | Progressive macrocephaly (HP:0004481) | 2.70403680 |
| 47 | Hypomagnesemia (HP:0002917) | 2.69555659 |
| 48 | Shallow orbits (HP:0000586) | 2.69035764 |
| 49 | Hamartoma of the eye (HP:0010568) | 2.65577726 |
| 50 | Premature rupture of membranes (HP:0001788) | 2.64974969 |
| 51 | Cortical dysplasia (HP:0002539) | 2.64429962 |
| 52 | Myocardial infarction (HP:0001658) | 2.62950609 |
| 53 | Malnutrition (HP:0004395) | 2.60726844 |
| 54 | Congenital stationary night blindness (HP:0007642) | 2.60468107 |
| 55 | Short hallux (HP:0010109) | 2.55568808 |
| 56 | Chronic hepatic failure (HP:0100626) | 2.53169577 |
| 57 | Furrowed tongue (HP:0000221) | 2.51048027 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.44985460 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.44465663 |
| 60 | Glycosuria (HP:0003076) | 2.44465663 |
| 61 | Peritonitis (HP:0002586) | 2.41871012 |
| 62 | True hermaphroditism (HP:0010459) | 2.39043782 |
| 63 | Biconcave vertebral bodies (HP:0004586) | 2.38428513 |
| 64 | Epidermoid cyst (HP:0200040) | 2.37439654 |
| 65 | Hemiparesis (HP:0001269) | 2.36621036 |
| 66 | Hyperglycemia (HP:0003074) | 2.33359876 |
| 67 | Hyperglycinemia (HP:0002154) | 2.32691470 |
| 68 | Hyperlipoproteinemia (HP:0010980) | 2.31189592 |
| 69 | Aortic dissection (HP:0002647) | 2.30828204 |
| 70 | Neoplasm of the adrenal gland (HP:0100631) | 2.30029954 |
| 71 | Abolished electroretinogram (ERG) (HP:0000550) | 2.29869342 |
| 72 | Neonatal short-limb short stature (HP:0008921) | 2.29161610 |
| 73 | Tetraparesis (HP:0002273) | 2.29107796 |
| 74 | Cervical subluxation (HP:0003308) | 2.28751638 |
| 75 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26899952 |
| 76 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.26880481 |
| 77 | Aortic aneurysm (HP:0004942) | 2.25856184 |
| 78 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.25096090 |
| 79 | Agitation (HP:0000713) | 2.24962457 |
| 80 | Late onset (HP:0003584) | 2.24267765 |
| 81 | Ileus (HP:0002595) | 2.23578073 |
| 82 | Fat malabsorption (HP:0002630) | 2.20105879 |
| 83 | Abnormality of midbrain morphology (HP:0002418) | 2.18850843 |
| 84 | Molar tooth sign on MRI (HP:0002419) | 2.18850843 |
| 85 | Conjugated hyperbilirubinemia (HP:0002908) | 2.18603187 |
| 86 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.16998683 |
| 87 | Depressed nasal tip (HP:0000437) | 2.15957151 |
| 88 | Acute necrotizing encephalopathy (HP:0006965) | 2.14369318 |
| 89 | Hypoalbuminemia (HP:0003073) | 2.14350388 |
| 90 | Abnormal albumin level (HP:0012116) | 2.14350388 |
| 91 | Hepatic necrosis (HP:0002605) | 2.13825334 |
| 92 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.13090854 |
| 93 | Male infertility (HP:0003251) | 2.12079563 |
| 94 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.10633406 |
| 95 | Abnormality of secondary sexual hair (HP:0009888) | 2.08987320 |
| 96 | Abnormality of the axillary hair (HP:0100134) | 2.08987320 |
| 97 | Abnormality of magnesium homeostasis (HP:0004921) | 2.08023573 |
| 98 | Broad metatarsal (HP:0001783) | 2.07523119 |
| 99 | Prominent metopic ridge (HP:0005487) | 2.07431858 |
| 100 | Stomatitis (HP:0010280) | 2.06954490 |
| 101 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.06890409 |
| 102 | Congenital sensorineural hearing impairment (HP:0008527) | 2.06395131 |
| 103 | Nephronophthisis (HP:0000090) | 2.04934714 |
| 104 | Vascular tortuosity (HP:0004948) | 2.03790736 |
| 105 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03488895 |
| 106 | Meningioma (HP:0002858) | 2.02524404 |
| 107 | Abnormality of the renal cortex (HP:0011035) | 2.02016448 |
| 108 | Abnormal drinking behavior (HP:0030082) | 2.02007508 |
| 109 | Polydipsia (HP:0001959) | 2.02007508 |
| 110 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.01120689 |
| 111 | Hypoplasia of the fovea (HP:0007750) | 2.01026578 |
| 112 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.01026578 |
| 113 | Aqueductal stenosis (HP:0002410) | 1.99738785 |
| 114 | Mitral valve prolapse (HP:0001634) | 1.98190116 |
| 115 | Increased circulating renin level (HP:0000848) | 1.97626155 |
| 116 | Pigmentary retinal degeneration (HP:0001146) | 1.97587504 |
| 117 | Infantile muscular hypotonia (HP:0008947) | 1.97488705 |
| 118 | Gaze-evoked nystagmus (HP:0000640) | 1.97464889 |
| 119 | Acute encephalopathy (HP:0006846) | 1.97065958 |
| 120 | Renal cortical cysts (HP:0000803) | 1.96697411 |
| 121 | Cubitus valgus (HP:0002967) | 1.95572848 |
| 122 | Medial flaring of the eyebrow (HP:0010747) | 1.95316683 |
| 123 | Short nail (HP:0001799) | 1.95182470 |
| 124 | Tarsal synostosis (HP:0008368) | 1.94689695 |
| 125 | Cardiovascular calcification (HP:0011915) | 1.94231904 |
| 126 | Arterial tortuosity (HP:0005116) | 1.93623376 |
| 127 | Hyperphosphatemia (HP:0002905) | 1.93461847 |
| 128 | Broad face (HP:0000283) | 1.92347771 |
| 129 | Progressive sensorineural hearing impairment (HP:0000408) | 1.91481503 |
| 130 | Tongue fasciculations (HP:0001308) | 1.90321892 |
| 131 | Type I diabetes mellitus (HP:0100651) | 1.89753625 |
| 132 | Goiter (HP:0000853) | 1.89727483 |
| 133 | Mitochondrial inheritance (HP:0001427) | 1.88409707 |
| 134 | Epileptiform EEG discharges (HP:0011182) | 1.87550549 |
| 135 | EEG with generalized epileptiform discharges (HP:0011198) | 1.85515326 |
| 136 | Abnormality of methionine metabolism (HP:0010901) | 1.85121405 |
| 137 | Abnormality of the nasal septum (HP:0000419) | 1.84140086 |
| 138 | Right ventricular cardiomyopathy (HP:0011663) | 1.83621084 |
| 139 | Turricephaly (HP:0000262) | 1.83077277 |
| 140 | Synostosis involving the elbow (HP:0003938) | 1.83009328 |
| 141 | Humeroradial synostosis (HP:0003041) | 1.83009328 |
| 142 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.82371883 |
| 143 | Abnormality of glycine metabolism (HP:0010895) | 1.82371883 |
| 144 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81134205 |
| 145 | Dicarboxylic aciduria (HP:0003215) | 1.81134205 |
| 146 | Coronal craniosynostosis (HP:0004440) | 1.78673434 |
| 147 | Chorioretinal atrophy (HP:0000533) | 1.78444732 |
| 148 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77719613 |
| 149 | Papillary thyroid carcinoma (HP:0002895) | 1.77634049 |
| 150 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.76616289 |
| 151 | Synostosis involving bones of the feet (HP:0009140) | 1.76616289 |
| 152 | Hypsarrhythmia (HP:0002521) | 1.76112833 |
| 153 | Hypoplasia of the uterus (HP:0000013) | 1.75772074 |
| 154 | Lethargy (HP:0001254) | 1.75680143 |
| 155 | Long nose (HP:0003189) | 1.75548303 |
| 156 | Pendular nystagmus (HP:0012043) | 1.75190013 |
| 157 | Hyperthyroidism (HP:0000836) | 1.74401358 |
| 158 | Urethral obstruction (HP:0000796) | 1.73589539 |
| 159 | Facial shape deformation (HP:0011334) | 1.73168115 |
| 160 | Potter facies (HP:0002009) | 1.73168115 |
| 161 | Abnormality of the renal medulla (HP:0100957) | 1.72899224 |
| 162 | Abnormality of the metopic suture (HP:0005556) | 1.72863237 |
| 163 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.72824633 |
| 164 | Hypoplastic toenails (HP:0001800) | 1.72724054 |
| 165 | Short middle phalanx of the 5th finger (HP:0004220) | 1.72204218 |
| 166 | Atrophic scars (HP:0001075) | 1.71946457 |
| 167 | Male pseudohermaphroditism (HP:0000037) | 1.71921917 |
| 168 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.70448638 |
| 169 | Enlarged penis (HP:0000040) | 1.70442459 |
| 170 | Confusion (HP:0001289) | 1.69069573 |
| 171 | Vascular calcification (HP:0004934) | 1.69051651 |
| 172 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.68624048 |
| 173 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.68135755 |
| 174 | Ectopia lentis (HP:0001083) | 1.66915046 |
| 175 | Fibular aplasia (HP:0002990) | 1.66570368 |
| 176 | Skin nodule (HP:0200036) | 1.66171294 |
| 177 | Abnormality of homocysteine metabolism (HP:0010919) | 1.64620836 |
| 178 | Homocystinuria (HP:0002156) | 1.64620836 |
| 179 | Bronchomalacia (HP:0002780) | 1.63959496 |
| 180 | Dilatation of the ascending aorta (HP:0005111) | 1.63822970 |
| 181 | Abnormality of purine metabolism (HP:0004352) | 1.61655987 |
| 182 | Craniofacial hyperostosis (HP:0004493) | 1.61489660 |
| 183 | Abnormality of incisor morphology (HP:0011063) | 1.59153649 |
| 184 | Abnormality of the common coagulation pathway (HP:0010990) | 1.58500471 |
| 185 | Genu recurvatum (HP:0002816) | 1.57337027 |
| 186 | Abnormal gallbladder physiology (HP:0012438) | 1.56960075 |
| 187 | Cholecystitis (HP:0001082) | 1.56960075 |
| 188 | Mitral stenosis (HP:0001718) | 1.56608567 |
| 189 | Hyperglycinuria (HP:0003108) | 1.56171064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 5.65479485 |
| 2 | LATS1 | 4.84876908 |
| 3 | MKNK2 | 4.69727027 |
| 4 | TNIK | 4.64830321 |
| 5 | TAOK3 | 3.13799524 |
| 6 | GRK1 | 2.89770859 |
| 7 | RIPK1 | 2.80979682 |
| 8 | ACVR1B | 2.60135568 |
| 9 | FRK | 2.52581734 |
| 10 | TRIB3 | 2.51828473 |
| 11 | MST4 | 2.42543823 |
| 12 | MOS | 2.39850766 |
| 13 | ERBB4 | 2.31583369 |
| 14 | LATS2 | 2.29852164 |
| 15 | MKNK1 | 2.28212172 |
| 16 | ADRBK2 | 2.17274040 |
| 17 | MAP4K2 | 1.98748522 |
| 18 | OXSR1 | 1.90166730 |
| 19 | PHKG1 | 1.85433301 |
| 20 | PHKG2 | 1.85433301 |
| 21 | STK38L | 1.81527952 |
| 22 | STK39 | 1.79431582 |
| 23 | ZAK | 1.78938603 |
| 24 | PINK1 | 1.76607171 |
| 25 | PASK | 1.69825509 |
| 26 | NUAK1 | 1.69763523 |
| 27 | STK3 | 1.53499680 |
| 28 | TRIM28 | 1.50196061 |
| 29 | CASK | 1.48898078 |
| 30 | LMTK2 | 1.40246823 |
| 31 | BMPR2 | 1.37222408 |
| 32 | STK24 | 1.33800170 |
| 33 | NTRK1 | 1.32917661 |
| 34 | PRKD3 | 1.32169761 |
| 35 | EPHA2 | 1.31487221 |
| 36 | EIF2AK3 | 1.31407426 |
| 37 | MAP2K7 | 1.30576012 |
| 38 | PIK3CA | 1.29747875 |
| 39 | DAPK2 | 1.28038981 |
| 40 | MAP3K4 | 1.26820599 |
| 41 | TTK | 1.26231270 |
| 42 | MAP3K6 | 1.25191367 |
| 43 | SIK1 | 1.22652913 |
| 44 | DDR2 | 1.22389759 |
| 45 | TAOK1 | 1.17476027 |
| 46 | STK10 | 1.16813814 |
| 47 | BMX | 1.16072483 |
| 48 | WNK4 | 1.13509977 |
| 49 | PLK3 | 1.13300355 |
| 50 | INSRR | 1.12909452 |
| 51 | TXK | 1.08640238 |
| 52 | PRKCE | 1.08072577 |
| 53 | TEC | 1.07871669 |
| 54 | KSR2 | 1.07829139 |
| 55 | MAP3K13 | 1.06131388 |
| 56 | PTK2 | 1.01537994 |
| 57 | BCKDK | 1.00250313 |
| 58 | ERBB3 | 0.99630810 |
| 59 | CSNK1G1 | 0.98108036 |
| 60 | PTK6 | 0.95628349 |
| 61 | PAK6 | 0.93068546 |
| 62 | MAP3K12 | 0.90920331 |
| 63 | TIE1 | 0.89856340 |
| 64 | IRAK1 | 0.89553698 |
| 65 | MST1R | 0.88646117 |
| 66 | ERN1 | 0.86663441 |
| 67 | PRKAA2 | 0.84781561 |
| 68 | PAK3 | 0.84401109 |
| 69 | BRAF | 0.83735004 |
| 70 | RET | 0.83538661 |
| 71 | PDGFRA | 0.78932517 |
| 72 | PLK2 | 0.78890147 |
| 73 | FER | 0.77284517 |
| 74 | MAP2K4 | 0.72814061 |
| 75 | NTRK3 | 0.72227243 |
| 76 | IKBKB | 0.70138539 |
| 77 | MAP3K9 | 0.69412112 |
| 78 | STK11 | 0.69290900 |
| 79 | BRSK2 | 0.69045107 |
| 80 | MAP3K8 | 0.67309964 |
| 81 | AKT3 | 0.67296619 |
| 82 | CSNK1G3 | 0.66172804 |
| 83 | TLK1 | 0.64872236 |
| 84 | HIPK2 | 0.63776664 |
| 85 | EPHA4 | 0.63642459 |
| 86 | ITK | 0.63092700 |
| 87 | MAP2K6 | 0.62972981 |
| 88 | PRKG2 | 0.62750492 |
| 89 | NTRK2 | 0.62114470 |
| 90 | EPHA3 | 0.61896203 |
| 91 | SGK3 | 0.60799952 |
| 92 | GRK7 | 0.60153449 |
| 93 | EEF2K | 0.59661860 |
| 94 | STK38 | 0.59607494 |
| 95 | MAPK13 | 0.58061560 |
| 96 | FGFR2 | 0.57093973 |
| 97 | ADRBK1 | 0.55696970 |
| 98 | MET | 0.53251243 |
| 99 | KSR1 | 0.53005304 |
| 100 | TRPM7 | 0.51260187 |
| 101 | PRKCQ | 0.51088897 |
| 102 | PRKAA1 | 0.49207956 |
| 103 | MAPKAPK3 | 0.49001272 |
| 104 | MELK | 0.48530365 |
| 105 | MAP2K1 | 0.48335539 |
| 106 | DMPK | 0.48172922 |
| 107 | STK16 | 0.47659005 |
| 108 | FGFR4 | 0.47434105 |
| 109 | BMPR1B | 0.46947310 |
| 110 | CHEK2 | 0.46934540 |
| 111 | LIMK1 | 0.45758396 |
| 112 | CAMK2D | 0.45570185 |
| 113 | FGFR1 | 0.44625602 |
| 114 | NLK | 0.44466019 |
| 115 | MAP3K2 | 0.44104386 |
| 116 | ROCK1 | 0.44092332 |
| 117 | JAK1 | 0.43780904 |
| 118 | MYLK | 0.43525045 |
| 119 | PRKCI | 0.42548369 |
| 120 | SGK2 | 0.42512468 |
| 121 | LRRK2 | 0.41940014 |
| 122 | PKN2 | 0.41550636 |
| 123 | CDK9 | 0.41324788 |
| 124 | TYRO3 | 0.40869719 |
| 125 | PLK4 | 0.40410520 |
| 126 | IKBKE | 0.40191008 |
| 127 | PAK2 | 0.39734961 |
| 128 | WNK3 | 0.39135025 |
| 129 | RAF1 | 0.38854814 |
| 130 | VRK1 | 0.38674578 |
| 131 | MAPK7 | 0.37934775 |
| 132 | CAMK2A | 0.37857538 |
| 133 | MAP3K7 | 0.37596150 |
| 134 | PRKACA | 0.37582207 |
| 135 | MAP3K1 | 0.37212077 |
| 136 | PRKCA | 0.36945105 |
| 137 | NEK9 | 0.35285850 |
| 138 | CSNK1A1 | 0.35272180 |
| 139 | ERBB2 | 0.34694824 |
| 140 | STK4 | 0.34485501 |
| 141 | RPS6KA4 | 0.33292574 |
| 142 | YES1 | 0.33227898 |
| 143 | PRKD2 | 0.32811525 |
| 144 | PRKCG | 0.30990915 |
| 145 | MTOR | 0.30766992 |
| 146 | CDK8 | 0.30417652 |
| 147 | FGFR3 | 0.30141366 |
| 148 | SGK1 | 0.29508769 |
| 149 | CAMKK2 | 0.29416812 |
| 150 | PLK1 | 0.28892322 |
| 151 | EPHB2 | 0.28861602 |
| 152 | CSNK1G2 | 0.28710982 |
| 153 | EGFR | 0.28579410 |
| 154 | IGF1R | 0.28469899 |
| 155 | MAPK11 | 0.28435955 |
| 156 | MAPK12 | 0.27052949 |
| 157 | PRKG1 | 0.26018441 |
| 158 | MAP3K10 | 0.25902157 |
| 159 | TTN | 0.24961569 |
| 160 | PTK2B | 0.24522504 |
| 161 | PRKACG | 0.24151139 |
| 162 | TYK2 | 0.23648778 |
| 163 | FLT3 | 0.23338180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.18207038 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.85722780 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.51644783 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.47080289 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39726588 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.30423061 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.28202793 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.11525030 |
| 9 | Bile secretion_Homo sapiens_hsa04976 | 1.99743778 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.98097629 |
| 11 | Circadian rhythm_Homo sapiens_hsa04710 | 1.95279643 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.94753800 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.90706833 |
| 14 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.89442493 |
| 15 | Mineral absorption_Homo sapiens_hsa04978 | 1.86828373 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.80595438 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77857003 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76215651 |
| 19 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.72344172 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.66686216 |
| 21 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.65132070 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.64949696 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.63265290 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61529639 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57470659 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57265210 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.55206441 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52095213 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47260206 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45034065 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.45009456 |
| 32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43239081 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42864334 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38763260 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.38459645 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33807740 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.33626043 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.29273324 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.29005705 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27126105 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24871193 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24122282 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.23281736 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22639973 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.21592338 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21522649 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19149297 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.16937727 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 1.15653276 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10991093 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08098125 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04128065 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.03369638 |
| 54 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.02520938 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01564308 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98918155 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98709937 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.98694942 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95140545 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.94447080 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.92931700 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92037631 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.90605582 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.88360127 |
| 65 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87501964 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86753954 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85978244 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85546161 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.85481499 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.85452984 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.82104268 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76589741 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74858783 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74458704 |
| 75 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74332483 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73747596 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71812547 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.70683734 |
| 79 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69776485 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69697474 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69241416 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68974535 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68460471 |
| 84 | RNA degradation_Homo sapiens_hsa03018 | 0.67560067 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60832931 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60231433 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59823089 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59394631 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57559934 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57411368 |
| 91 | * Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57202367 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57119107 |
| 93 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.56819421 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56347586 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.54805925 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53116926 |
| 97 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52984370 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52761824 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52260295 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52257058 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51751928 |
| 102 | Proteasome_Homo sapiens_hsa03050 | 0.51119729 |
| 103 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49853003 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49246053 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49109060 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49106944 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49066614 |
| 108 | Melanoma_Homo sapiens_hsa05218 | 0.48143901 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47514320 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47164382 |
| 111 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46328791 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.45929702 |
| 113 | RNA polymerase_Homo sapiens_hsa03020 | 0.45876050 |
| 114 | Taste transduction_Homo sapiens_hsa04742 | 0.45768299 |
| 115 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45721992 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.45447197 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.44169690 |
| 118 | Salivary secretion_Homo sapiens_hsa04970 | 0.43461484 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43343437 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42874194 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41829661 |
| 122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41504189 |
| 123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40562696 |
| 124 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40226871 |
| 125 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39078532 |
| 126 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38140137 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37918244 |
| 128 | Homologous recombination_Homo sapiens_hsa03440 | 0.37730435 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36572212 |
| 130 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36384768 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35961276 |
| 132 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35066019 |
| 133 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35031945 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34978322 |
| 135 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.34957791 |
| 136 | Purine metabolism_Homo sapiens_hsa00230 | 0.33861508 |
| 137 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33680560 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33290473 |
| 139 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32987785 |
| 140 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32743239 |
| 141 | Glioma_Homo sapiens_hsa05214 | 0.31857042 |
| 142 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31129479 |
| 143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30965793 |
| 144 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30602452 |
| 145 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30142876 |
| 146 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.28591761 |
| 147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28181093 |
| 148 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.27965534 |
| 149 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.26392531 |

